Erinn Thomas-Mackey
About Erinn Thomas-Mackey
Erinn Thomas-Mackey, DVM, age 38, has served as an independent director of Inspire Veterinary Partners (IVP) since August 2023. She holds a B.S. in Biology and a Bachelor of Animal, Poultry, and Veterinary Science (2010) and a Doctor of Veterinary Medicine (2014), all from Tuskegee University, and brings hands-on emergency and general practice veterinary experience alongside practice ownership and real estate management credentials .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Assisi Veterinary Hospital (Malverne, NY) | Associate General Practice Veterinarian | Jun 2015 – Jun 2017 | Direct patient care; experience with practice operations |
| Animal Emergency Service (Long Island, NY) | Associate Emergency Veterinarian | Aug 2017 – Oct 2021 | Emergency medicine; operational challenges in high-acuity settings |
| TwoMacks Properties LLC | Managing Member & Founder | 2019 – present | Real estate negotiation, evaluation, and property management |
| Thomas-Mackey Veterinary Service | Managing Member & Founder | 2021 – present | Per-diem veterinary practice operations and staffing optimization |
| SeaPath Advisory LLC | Founder & Managing Member | 2022 – present | Advisory services; revenue optimization and practice flow |
External Roles
| Organization | Role | Tenure | Notes |
|---|---|---|---|
| SeaPath Advisory LLC | Founder & Managing Member | 2022 – present | Private advisory; not a public company board |
| Thomas-Mackey Veterinary Service | Managing Member & Founder | 2021 – present | Private practice; not a public company board |
| TwoMacks Properties LLC | Managing Member & Founder | 2019 – present | Private real estate entity; not a public company board |
| Other public company boards | — | — | None disclosed in IVP proxy biographies |
Board Governance
- Independence: The Board determined Dr. Thomas-Mackey is independent under Nasdaq rules; in 2025 she is listed as independent and serving on the Compensation Committee .
- Committee assignments:
- 2024: Audit Committee member (with Watters as Chair; committee met three times in 2024) .
- 2025: Compensation Committee member (Anne Murphy as Chair; committee met four times in 2024) .
- Attendance: The Board held four meetings in 2024; each director attended at least 75% of Board and applicable committee meetings. Three of eight directors attended the 2024 annual meeting (directors were encouraged, not required, to attend) .
- Executive sessions: Non-management directors meet in executive session at each quarterly board meeting .
- Leadership structure: CEO also serves as Chair; the Board has not appointed a lead independent director .
Fixed Compensation
| Component | Amount | Notes |
|---|---|---|
| Annual cash retainer | $36,000 | Non-employee directors; payable monthly |
| Annual committee fee | $5,000 | For non-employee directors serving on one or more committees; payable annually |
| 2024 Fees Earned (Erinn Thomas-Mackey) | $41,000 | As disclosed for fiscal year ended 12/31/2024 |
Performance Compensation
| Award Detail | Value | Notes |
|---|---|---|
| Option grant – grant date | Sep 26, 2024 | Directors serving at that time received options; fully vested at grant |
| Exercise price | $17 per share | Closing price on Nasdaq on grant date; adjusted for 1-for-25 reverse split in Jan 2025 |
| Grant-date fair value (Erinn Thomas-Mackey) | $3,618 | ASC 718 fair value; fully vested on grant date |
| Options outstanding (as of 12/31/2024) | 1,447 | Unvested: 0 |
| Performance conditions | None disclosed | Options were fully vested upon grant; no performance metrics tied to director equity |
Clawback policy: IVP adopted an executive incentive compensation recovery policy pursuant to Exchange Act Rule 10D-1 and Nasdaq Listing Rule 5608; administered by the Compensation Committee and applies to incentive-based executive compensation upon accounting restatements .
Other Directorships & Interlocks
| Category | Detail |
|---|---|
| Current public company boards | None disclosed for Dr. Thomas-Mackey in IVP proxies |
| Committee roles at other public companies | None disclosed |
Expertise & Qualifications
- Veterinary credentials: DVM (2014) and dual bachelor’s degrees (2010) from Tuskegee University; extensive emergency and general practice experience .
- Practice operations: Experience in staffing, practice flow optimization, and revenue growth for veterinary practices .
- Real estate and entrepreneurship: Negotiation, property evaluation, and management through TwoMacks Properties; founder of advisory and practice entities .
Equity Ownership
| Holder | Class | Shares Beneficially Owned | % of Class | Notes |
|---|---|---|---|---|
| Erinn Thomas-Mackey | Class A common | 1,449 | <1% (*) | As of Oct 14, 2025; “*” denotes less than 1% |
| Erinn Thomas-Mackey | Class B common | — | — | None |
| Options outstanding | N/A | 1,447 | N/A | Unvested: 0 |
| Shares outstanding (reference) | Class A: 3,647,610; Class B: 3,020,750 | — | — | For % calculations in proxy table |
Governance Assessment
- Strengths:
- Independent director with sector-relevant operational expertise; currently serves on the Compensation Committee (independent composition) .
- Prior Audit Committee service in 2024 and participation in audit oversight (Audit Committee report lists her as a member), supporting board effectiveness on controls .
- Documented director attendance threshold compliance (≥75%) and quarterly executive sessions that support independent discussion .
- Adoption of an executive clawback policy aligned with Nasdaq Rule 5608; oversight by the Compensation Committee .
- Risks and red flags impacting investor confidence (board-level environment):
- CEO-Chair combination with no lead independent director, which can weaken independent oversight during strategic or compensation deliberations .
- Dual-class structure with Class B carrying 25 votes per share; significant voting concentration including 71.2% of Class B beneficially owned by a director-affiliated entity (Wilderness Trace Veterinary Partners, LLC), potentially diluting minority shareholder influence .
- Multiple related-party transactions (e.g., Blue Heron Consulting tied to director Charles Stith Keiser; sale of KVC to an entity involving his father; past consulting with CEO-affiliated Star Circle), increasing perceived conflict risk and the need for rigorous Audit Committee review .
Net takeaway: Dr. Thomas-Mackey appears independent, engaged, and committee-active, with operational veterinary expertise valuable to IVP’s business model. However, overall board governance quality is influenced by structural risks (CEO-Chair consolidation, no lead independent director, dual-class voting concentration, and recurring related-party dealings), which investors should factor into board effectiveness and oversight assessments .